Jade Biosciences Inc (JBIO) returns

NASDAQ · Health Care

$14.06 -1.26% Close Oct 30, 2026 Live

Jade Biosciences returns over 5 years

$1,000 invested in Jade Biosciences five years ago was worth $31.19 at the close on October 30, 2026, with dividends reinvested: an average return of -50.0% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.

JBIO, $10,000 investedS&P 500 (SPY)
$100.00$1,000$10,000
20222023202420252026

Total return by period

With dividends reinvested, to the close on Oct 30, 2026. A year means 365 days.
PeriodTotal returnA year, on average$1,000 becameS&P 500 (SPY)
1 month +0.1% — $1,001 -0.9%
3 months -29.7% — $703.00 +2.1%
Year to date -8.9% — $911.21 +11.7%
1 year +42.7% — $1,427 +12.4%
3 years -95.0% -63.2% $49.78 +88.5%
5 years -96.9% -50.0% $31.19 +76.0%

Jade Biosciences return by calendar year

YearJBIOS&P 500 (SPY)Difference
2026 to date -8.9% +11.7% -20.6%
2025 -79.4% +17.7% -97.1%
2024 -88.3% +24.9% -113.2%
2023 -22.8% +26.2% -49.0%
2022 +148.5% -18.2% +166.7%

Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.

See also:

No forecast, no recommendation. This page describes Jade Biosciences Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.